CSIMarket
 


Gw Pharmaceuticals Plc  (GWPH)
Other Ticker:  
 

Gw Pharmaceuticals Plc's Leverage Ratio

GWPH's quarterly Leverage Ratio and Total Liabilities, Equity growth


Despite a net increase in borrowings by 0.2%, Gw Pharmaceuticals Plc managed to enhance Leverage Ratio in the first quarter 2021 to 0.23, achieving a new company high.

Within Major Pharmaceutical Preparations industry in the first quarter 2021, 223 other companies have achieved lower Leverage Ratio than Gw Pharmaceuticals Plc in the I Quarter 2021. While Leverage Ratio total ranking has deteriorated compared to the forth quarter 2020 from 746 to 756 .

Explain Leverage Ratio?
Who are GWPH Customers?
What are GWPH´s Total Liabilities?


GWPH Leverage Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Change 2.99 % 2.07 % 2.06 % -1.64 % 11.77 %
Y / Y Total Liabilities Change 49.92 % 32.44 % 42.59 % 38.31 % 30.27 %
Leverage Ratio MRQ 0.23 0.23 0.21 0.18 0.16
GWPH's Total Ranking # 756 # 746 # 473 # 340 # 186
Seq. Equity Change -0.64 % 0.9 % 2.44 % 0.27 % -1.52 %
Seq. Total Liabilities Change 0.2 % 13.15 % 17.12 % 12.9 % -11.48 %



Leverage Ratio first quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 224
Healthcare Sector # 380
Overall Market # 756


Leverage Ratio Statistics
High Average Low
0.23 0.17 0.12
(Mar 31 2021)   (Dec 31 2018)




Financial Statements
Gw Pharmaceuticals Plc's Equity $ 736 Millions Visit GWPH's Balance sheet
Gw Pharmaceuticals Plc's Total Liabilities $ 171 Millions Visit GWPH's Balance sheet
Source of GWPH's Sales Visit GWPH's Sales by Geography


Cumulative Gw Pharmaceuticals Plc's Leverage Ratio

GWPH's Leverage Ratio for the trailling 12 Months

GWPH Leverage Ratio

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity TTM Growth 2.99 % 2.07 % 2.06 % -1.64 % 11.77 %
Y / Y Total Liabilities TTM Growth 49.92 % 32.44 % 42.59 % 38.31 % 30.27 %
Leverage Ratio TTM 0.21 0.19 0.18 0.17 0.15
Total Ranking TTM # 569 # 468 # 402 # 359 # 360
Seq. Equity TTM Growth -0.64 % 0.9 % 2.44 % 0.27 % -1.52 %
Seq. Total Liabilities TTM Growth 0.2 % 13.15 % 17.12 % 12.9 % -11.48 %


On the trailing twelve months basis Due to the net new borrowings of 0.2% during the trailing twelve months finishing in the I Quarter 2021, cumulativeLeverage Ratio improved to 0.21, above the Gw Pharmaceuticals Plc's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry GWPH recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2021, compared to the prior period, from 16 to 531.

Explain Leverage Ratio?
Who are GWPH Customers?
What are GWPH´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Within the Market # 756


trailing twelve months Leverage Ratio Statistics
High Average Low
0.25 0.2 0.16
(Mar 31 2021)   (Jun 30 2019)




Companies with similar Leverage Ratio in the quarter ending Mar 31 2021, within Major Pharmaceutical Preparations Industry Leverage RatioMar 31 2021 MRQ Total LiabilitiesMar 31 2021 MRQ Equity
Evotec Se  0.62 $ 960.373  Millions$ 1,543.007  Millions
Elite Pharmaceuticals Inc   0.62 $ 10.038  Millions$ 16.152  Millions
Prothena Corporation Public Limited Company  0.62 $ 145.135  Millions$ 234.584  Millions
Nexien Biopharma Inc   0.61 $ 0.013  Millions$ 0.021  Millions
Exicure Inc   0.61 $ 30.561  Millions$ 50.041  Millions
Ardelyx Inc   0.61 $ 79.482  Millions$ 130.811  Millions
Vyne Therapeutics Inc   0.61 $ 56.270  Millions$ 92.901  Millions
Cti Biopharma Corp   0.61 $ 16.135  Millions$ 26.654  Millions
Qualigen Therapeutics Inc   0.59 $ 9.505  Millions$ 16.230  Millions
Heron Therapeutics Inc   0.58 $ 114.707  Millions$ 196.225  Millions
Clearside Biomedical Inc   0.58 $ 9.920  Millions$ 16.985  Millions
Mainz Biomed N v   0.58 $ 3.680  Millions$ 6.361  Millions
Sigilon Therapeutics Inc   0.58 $ 74.353  Millions$ 129.032  Millions
Bicycle Therapeutics Plc  0.55 $ 78.726  Millions$ 142.091  Millions
Kiora Pharmaceuticals Inc  0.55 $ 6.964  Millions$ 12.685  Millions
Medicure Inc   0.54 $ 7.658  Millions$ 14.103  Millions
Adial Pharmaceuticals Inc   0.54 $ 3.008  Millions$ 5.618  Millions
Sinovac Biotech Ltd  0.53 $ 7,420.739  Millions$ 13,876.009  Millions
Kazia Therapeutics Limited  0.53 $ 20.237  Millions$ 37.851  Millions
Dr Reddy s Laboratories Limited  0.53 $ 1,264.000  Millions$ 2,366.000  Millions
Amphastar Pharmaceuticals Inc   0.53 $ 240.180  Millions$ 450.960  Millions
Corbus Pharmaceuticals Holdings Inc   0.53 $ 48.628  Millions$ 91.517  Millions
Prophase Labs Inc   0.53 $ 27.798  Millions$ 52.665  Millions
Intec Pharma Ltd   0.52 $ 5.908  Millions$ 11.344  Millions
Aeterna Zentaris Inc   0.51 $ 27.116  Millions$ 52.986  Millions
F star Therapeutics Inc   0.51 $ 17.627  Millions$ 34.840  Millions
Elicio Therapeutics Inc   0.51 $ 46.757  Millions$ 92.443  Millions
Contrafect Corporation  0.50 $ 31.202  Millions$ 61.905  Millions
Alexion Pharmaceuticals Inc   0.50 $ 6,233.400  Millions$ 12,431.000  Millions
Abeona Therapeutics Inc   0.50 $ 47.042  Millions$ 94.390  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com